KIN001-266

response biomarkers — cross-omics
Drug responseDRUG → PROTEIN-RPPACell line

Across CCLE and GDSC cell-line panels, response to KIN001-266 is significantly associated with the total protein of multiple proteins, with BLOOD_Lymphoma cell lines showing a particularly strong set of associations.

The most reproducible KIN001-266 response-associated proteins across cancer lineages are p62 Lck ligand, 14-3-3_epsilon, and Annexin_VII, each associated with drug response in up to 7 lineages. Since the analysis identifies associations rather than directional relationships, both response-to-biomarker and biomarker-to-response views are provided.

Each biomarker is linked to its corresponding Q-omics profile. The scatter plot shows the strongest observed association, KIN001-266 response versus p62 Lck ligand total protein in BLOOD_Lymphoma (Pearson r = -0.50).

Total protein biomarkers of KIN001-266 response

Ranked by combined sampling and lineage consensus. X-score (response→biomarker) and Y-score (biomarker→response) are standardized regression coefficients; both directions are reported because the association is undirected. The reported p-values are derived from the association test.
LineagePartner proteinX-scoreY-scorep(X)p(Y)Sampling consensusLineage consensus
BLOOD_Lymphomap62 Lck ligand →-1.373-0.417.006.00437
BONE14-3-3_epsilon →+0.290+1.352.035<.00136
BLOOD_LeukemiaAnnexin_VII →-0.440-0.293.007.01236
BREASTMSH2 →+0.502+0.489.007.01835
LIVERAkt →+1.079+0.862.024.02435
BONEHER2_pY1248 →-0.581-1.236.001.00235
Each biomarker links to its Q-omics profile. Showing the 6 strongest associations by consensus.

KIN001-266 response vs p62 Lck ligand — BLOOD_Lymphoma

Per-cell-line scatter of KIN001-266 response vs p62 Lck ligand total protein in BLOOD_Lymphoma.

Explore this scatter interactively →

Exploration